Clinical Trial Update: Double Filtration Plasmapheresis for Hepatitis C Virus (HCV) Genotype 1 Patients With High Viral Load [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating double filtration plasmapheresis for Hepatitis C genotype 1 patients with high viral load was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hepatitis C | Phase 4 | Status: TERMINATED